Does Pro12Ala Polymorphism Enhance the Physiological Role of PPAR2?
Authors:
Open Access
- 31 July 2013
- journal article
- research article
- Published by Hindawi Limited in PPAR Research
- Vol. 2013, 1-8
Abstract
Obesity and type 2 diabetes mellitus (T2D) are two major public health problems that have motivated the scientific community to investigate the high contribution of genetic factors to these disorders. The peroxisome proliferator activated by gamma 2 (PPAR2) plays an important role in the lipid metabolism. Since PPAR2 is expressed mainly in adipose tissue, a moderate reduction of its activity influences the sensitivity to insulin, diabetes, and other metabolic parameters. The present study aims to contribute to the elucidation of the impact of the Pro12Ala polymorphism associated with T2D and obesity through a meta-analysis study of the literature that included approximately 11500 individuals, from which 3870 were obese and 7625 were diabetic. Statistical evidence supports protective effect in T2D of polymorphism Pro12Ala of PPAR2 (OR = 0.702 with 95% CI: 0.622; 0.791,). Conversely the same polymorphism Pro12Ala of PPAR2 seems to favor obesity since 1.196 more chance than nonobese was found (OR = 1.196 with 95% CI: 1.009; 1.417,). Our results suggest that Pro12Ala polymorphism enhances both adipogenic and antidiabetogenic physiological role of PPAR. Does Pro12Ala polymorphism represent an evolutionary step towards the stabilization of the molecular function of PPARtranscription factor signaling pathway?
Keywords
This publication has 27 references indexed in Scilit:
- The PPARγ Pro12Ala variant is associated with insulin sensitivity in Russian normoglycaemic and type 2 diabetic subjectsDiabetes & Vascular Disease Research, 2009
- Impact of the Pro12Ala Polymorphism of the PPAR‐Gamma 2 Gene on Metabolic and Clinical Characteristics in the Palestinian Type 2 Diabetic PatientsPPAR Research, 2009
- PPARγ2Pro12Ala Polymorphism and Human HealthPPAR Research, 2009
- Characterization of a Novel Polymorphism in PPARG Regulatory Region Associated with Type 2 Diabetes and Diabetic Retinopathy in ItalyBioMed Research International, 2008
- The PPAR resource pageBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2007
- Free fatty acids and insulin resistanceCurrent Opinion in Clinical Nutrition and Metabolic Care, 2007
- Role of interaction between variants in the PPARG and interleukin-6 genes on obesity related metabolic risk factorsExperimental Gerontology, 2005
- The peroxisome proliferator activated receptorφ2 (PPARφ2) Pro12Ala variant: lack of association with type 2 diabetes in obese and non obese Tunisian patientsDiabetes & Metabolism, 2005
- Global and societal implications of the diabetes epidemicNature, 2001
- The Pro115Gln and Pro12Ala PPAR gamma gene mutations in obesity and type 2 diabetesInternational Journal of Obesity, 2000